Cancer patients enrolled in Humana Medicare Advantage plans who receive treatment at Moffitt Cancer Center in Tampa face a forced choice this month: switch to a different insurance plan or absorb out-of-network costs for their ongoing care. The network exit strips in-network access to one of the nation’s top cancer treatment facilities for an undisclosed number of Medicare Advantage enrollees, compressing their decision window into weeks rather than months. Federal rules require standardized notices spelling out appeal and grievance rights, but the speed of the disruption raises questions about whether patients can act before their coverage terms change.
Why Moffitt’s exit from Humana’s network puts patients in a bind
When a major cancer center drops out of a Medicare Advantage network, the consequences land hardest on patients mid-treatment. Switching oncologists or facilities during chemotherapy, radiation, or immunotherapy cycles can delay care, disrupt clinical trial enrollment, and introduce new providers unfamiliar with a patient’s history. For enrollees who stay with Humana, continuing at Moffitt means paying out-of-network rates, which in cancer care can run tens of thousands of dollars per treatment cycle.
The central question for affected patients is whether they received notice early enough to file grievances, request continuity-of-care exceptions, or switch plans before the change takes effect. CMS requires Medicare Advantage plans to issue standardized notices that explain grievance procedures, coverage determinations, and appeal rights when network access changes. Patients who receive those notices with adequate lead time have a realistic path to challenge the disruption or secure alternative coverage. Those who learn about the exit late face a much narrower set of options.
The hypothesis that early notice drives higher grievance and appeal filing rates has a practical logic: patients who know their rights and deadlines are more likely to use them. But the absence of public data on how many Humana enrollees at Moffitt received timely notification, or how many have already filed complaints, makes it impossible to measure that effect in this case. For now, patient advocates are left to infer likely impacts from the structure of federal rules and the lived experience of people trying to navigate a complex benefits system while seriously ill.
Federal notice rules and the regulatory framework behind network changes
Federal regulation sets the floor for how Medicare Advantage plans must handle disruptions. The regulatory text at 42 CFR 422.510, which governs termination of Medicare Advantage contracts by CMS, includes explicit enrollee notification timing requirements. While that provision addresses plan-level contract terminations rather than individual provider-network exits, it establishes the principle that beneficiaries deserve advance warning and clear instructions when their coverage changes…